Myung-Sik Choi Selected Research

Scrub Typhus (Typhus, Scrub)

1/2019	Immunization with a recombinant antigen composed of conserved blocks from TSA56 provides broad genotype protection against scrub typhus.
1/2018	A Type I Interferon and IL-10 Induced by Orientia tsutsugamushi Infection Suppresses Antigen-Specific T Cells and Their Memory Responses.
1/2018	Comparative Study of Two Droplet-Based Dissolving Microneedle Fabrication Methods for Skin Vaccination.
12/2017	Longevity of antibody and T-cell responses against outer membrane antigens of Orientia tsutsugamushi in scrub typhus patients.
1/2017	Diversification of Orientia tsutsugamushi genotypes by intragenic recombination and their potential expansion in endemic areas.
11/2016	Generation of protective immunity against Orientia tsutsugamushi infection by immunization with a zinc oxide nanoparticle combined with ScaA antigen.
3/2015	Immunization with an autotransporter protein of Orientia tsutsugamushi provides protective immunity against scrub typhus.
9/2012	Detection of antibodies against Orientia tsutsugamushi Sca proteins in scrub typhus patients and genetic variation of sca genes of different strains.
1/2005	Chemokine and cytokine production in susceptible C3H/HeN mice and resistant BALB/c mice during Orientia tsutsugamushi infection.
1/2004	Chemokine and cytokine production during Orientia tsutsugamushi infection in mice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Myung-Sik Choi Research Topics

Disease

13	Infections 01/2018 - 01/2004
11	Scrub Typhus (Typhus, Scrub) 01/2019 - 05/2003
2	Epidemic Louse-Borne Typhus (Typhus) 02/2005 - 01/2005
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Bites and Stings (Sting) 01/2018
1	Coinfection 01/2018
1	Bacteremia 01/2018
1	Virus Diseases (Viral Diseases) 01/2017
1	Chronic Hepatitis C 01/2017
1	Hepatitis C 01/2017
1	Pneumonia (Pneumonitis) 01/2016
1	Neoplasms (Cancer) 03/2015
1	Typhoid Fever (Typhoid) 12/2005
1	Spotted Fever Group Rickettsiosis (Rickettsialpox) 02/2005
1	Inflammation (Inflammations) 01/2004
1	Rickettsia Infections 05/2003
1	Ulcerative Colitis 01/2002

Drug/Important Bio-Agent (IBA)

7	AntigensIBA 01/2019 - 05/2003
6	Proteins (Proteins, Gene)FDA Link 03/2015 - 04/2004
4	VaccinesIBA 01/2019 - 01/2012
4	ChemokinesIBA 01/2016 - 01/2002
2	Nucleic AcidsIBA 01/2018 - 02/2005
2	Antiviral Agents (Antivirals)IBA 01/2018 - 01/2017
2	Interferon Type IIBA 01/2018 - 01/2017
2	EnzymesIBA 12/2017 - 05/2003
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017 - 02/2005
2	AntibodiesIBA 09/2012 - 01/2005
2	Immunoglobulin M (IgM)IBA 01/2005 - 05/2003
2	CytokinesIBA 01/2005 - 01/2004
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	Ribavirin (Virazole)FDA LinkGeneric 01/2017
1	Peptides (Polypeptides)IBA 11/2016
1	Zinc Oxide FDA Link 11/2016
1	Bacterial AntigensIBA 11/2016
1	pyrithione zinc (ZPT)FDA Link 11/2016
1	Peptide LibraryIBA 11/2016
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2015
1	Type V Secretion SystemsIBA 03/2015
1	1- (6- ((3- methoxyestra- 1,3,5(10)- trien- 17- yl)amino)hexyl)- 1H- pyrrole- 2,5- dioneIBA 06/2011
1	Egtazic Acid (EGTA)IBA 06/2011
1	Chelating AgentsIBA 06/2011
1	1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl esterIBA 06/2011
1	GTP Phosphohydrolases (GTPases)IBA 05/2010
1	src-Family KinasesIBA 05/2010
1	Focal Adhesion Protein-Tyrosine KinasesIBA 05/2010
1	TalinIBA 05/2010
1	PaxillinIBA 05/2010
1	IntegrinsIBA 05/2010
1	Integrin alpha5beta1IBA 05/2010
1	ClathrinIBA 07/2006
1	QuinolonesIBA 12/2005
1	Nalidixic Acid FDA Link 12/2005
1	Complementary DNA (cDNA)IBA 04/2004
1	Heparin (Liquaemin)FDA LinkGeneric 04/2004
1	Heparin Lyase (heparin lyase)IBA 04/2004
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 04/2004
1	Syndecan-4IBA 04/2004
1	SyndecansIBA 04/2004
1	Heparitin Sulfate (Heparan Sulfate)IBA 04/2004
1	ImmunosorbentsIBA 05/2003
1	CC ChemokinesIBA 01/2002
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2002

Therapy/Procedure

1	Therapeutics 01/2017